Presenter: Molly Rodden, MSN, FNP-C, PMHNP-C

Original Date: December 4, 2021

Presentation Overview or Summary Outline:

1) Overview of Adjustment Disorder per DSM V criteria.

2) Overview of Major Depressive Disorder per DSM V criteria.

3) Discussion of differences and similarities including time frame.

4) Discussion of ethical considerations when treating Depression in what may be a time limited condition.

5) Discussion of "big picture thinking" in regards to treatment of what may be a time limited condition.

6) Picking agents and discussing options with the patient.

7) Considerations for Agent: ease of titration and discontinuation, potential/ probability of SE.

8) Consideration for treatment: clients perception, likelihood of remission, history of previous illness, overall impact (to multiple domains) to ADL/ quality of life/ cognitive function.

9) Answer questions.

This seminar will discuss the pharmaceuticals:

• SSRI - Zoloft, Lexapro, Celexa, Prozac SNRI- Effexor, Wellbutrin, Cymbalta Mood Stabilizer- Lamictal

0.75 general, 0.5 pharm, 0.25 ethics CEUs approved by OBNM